{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:31Z","timestamp":1781308711676,"version":"3.54.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144494","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T18:34:17Z","timestamp":1449772457000},"page":"e0144494","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers"],"prefix":"10.1371","volume":"10","author":[{"given":"Martin","family":"K\u00e4chele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita M.","family":"Hennige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Machann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Hieronimus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolia","family":"Lamprinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Machicao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Staiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1242\/jcs.093773","article-title":"Classes of phosphoinositide 3-kinases at a glance","volume":"127","author":"S Jean","year":"2014","journal-title":"J Cell Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"JA Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JOE-07-0097","article-title":"Phosphoinositide 3-kinases as a common platform for multi-hormone signaling","volume":"194","author":"E Hirsch","year":"2007","journal-title":"J Endocrinol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-OH kinase as a direct target of Ras","volume":"370","author":"P Rodriguez-Viciana","year":"1994","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cell.2013.04.031","article-title":"RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms","volume":"153","author":"R Fritsch","year":"2013","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"ra89","DOI":"10.1126\/scisignal.2003264","article-title":"G protein-coupled receptor-mediated activation of p110beta by Gbetagamma is required for cellular transformation and invasiveness","volume":"5","author":"HA Dbouk","year":"2012","journal-title":"Sci Signal"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1083\/jcb.200210115","article-title":"Roles of G beta gamma in membrane recruitment and activation of p110 gamma\/p101 phosphoinositide 3-kinase gamma","volume":"160","author":"C Brock","year":"2003","journal-title":"J Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"20312","DOI":"10.1073\/pnas.0905506106","article-title":"Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87\/p110gamma","volume":"106","author":"B Kurig","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"18862","DOI":"10.1073\/pnas.1304801110","article-title":"Molecular determinants of PI3Kgamma-mediated activation downstream of G-protein-coupled receptors (GPCRs)","volume":"110","author":"O Vadas","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome","volume":"2014","author":"J Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of Fatty liver","volume":"29","author":"N Stefan","year":"2008","journal-title":"Endocr Rev"},{"key":"ref12","first-page":"174","article-title":"Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences","volume":"71","author":"MM van Greevenbroek","year":"2013","journal-title":"Neth J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm1291","article-title":"PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus","volume":"11","author":"DF Barber","year":"2005","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/CIRCULATIONAHA.107.720466","article-title":"Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes","volume":"117","author":"A Fougerat","year":"2008","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1073\/pnas.0702663104","article-title":"Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis","volume":"104","author":"JD Chang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/nyas.12037","article-title":"Inhibition of phosphoinositide 3-kinase gamma attenuates inflammation, obesity, and cardiovascular risk factors","volume":"1280","author":"MP Wymann","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E854","DOI":"10.1073\/pnas.1106698108","article-title":"PI3Kgamma within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance","volume":"108","author":"B Becattini","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1007\/s00125-005-1948-3","article-title":"Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat","volume":"48","author":"N Stefan","year":"2005","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/dc07-1558","article-title":"Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions","volume":"31","author":"K Kantartzis","year":"2008","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmri.20292","article-title":"Standardized assessment of whole body adipose tissue topography by MRI","volume":"21","author":"J Machann","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mrm.20825","article-title":"Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy","volume":"55","author":"J Machann","year":"2006","journal-title":"Magn Reson Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/diacare.26.5.1395","article-title":"Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp","volume":"26","author":"D Tripathy","year":"2003","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinchem\/35.2.265","article-title":"A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma","volume":"2","author":"W Patsch","year":"1989","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"M Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e14194","DOI":"10.1371\/journal.pone.0014194","article-title":"Evaluation of fasting state-\/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired beta-cell function","volume":"5","author":"SA Herzberg-Schafer","year":"2010","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"CJ Willer","year":"2013","journal-title":"Nat Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1073\/pnas.1317023110","article-title":"Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants","volume":"110","author":"SC Parker","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1194\/jlr.M018887","article-title":"Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kgamma-dependent fluid-phase pinocytosis of native LDL","volume":"53","author":"JJ Anzinger","year":"2012","journal-title":"J Lipid Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2010.10.024","article-title":"Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort","volume":"214","author":"PT Williams","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11886-013-0349-3","article-title":"HDL cholesterol and cardiovascular outcomes: what is the evidence?","volume":"15","author":"M Rubenfire","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11886-013-0400-4","article-title":"How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?","volume":"15","author":"FK Welty","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"PJ Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"GG Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"WE Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"MJ Landray","year":"2014","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","author":"D Keene","year":"2014","journal-title":"BMJ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"A Rohatgi","year":"2014","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T12:48:38Z","timestamp":1599914918000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144494"}},"subtitle":[],"editor":[{"given":"Yanqiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144494","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]}}}